Le Lézard
Classified in: Health, Business
Subjects: LIC, CFG, MAT

RMMI Corp. Announces Receipt of its Cultivation, Processing and Medical Sales License from Health Canada


/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS./

CALGARY, Oct. 15, 2019 /CNW/ - RMMI Corp. ("RMMI" or the "Company"), (CSE: RMMI) is pleased to announce that its wholly-owned subsidiary, Rocky Mountain Marijuana Inc., has received its cultivation, processing and medical sales license (the "License") from Health Canada. The License is valid for a three-year period and renewable prior to its expiry date.

RMMI Corp. (CNW Group/RMMI)

The newly licensed section of the Newell facility includes a flower room, the mother-plant room and the cloning room, as well as the necessary auxiliary rooms to support cannabis operations. RMMI will commence its test-cultivations immediately upon completion of some utility system modifications. To expedite ramp-up of its cultivation capacity, the Company designed its Newell facility to allow for continuous cannabis operations while completing the remaining seven flower rooms, which are already partially installed. RMMI will commence completion of these rooms shortly. Since the Company is now licensed by Health Canada, cultivation rooms can be added to its License through a short license-amendment process. At full production, the Newell facility is designed to produce an estimated yield of 6,000 ? 7,000 kilograms per year.

Earl Connors, President and Chief Executive Officer of RMMI, stated: "The receipt of our License from Health Canada is a significant milestone in a long journey and marks the beginning of an even greater drive towards becoming an industry leader in the production of high-purity, organic-quality cannabis and cannabis oils by blending science with nature, using aeroponic cultivation systems. While we celebrate this accomplishment, it serves as a renewal of our commitment and enthusiasm to continue to execute our business strategy and create value for our shareholders, employees and stakeholders. With License in hand, RMMI will reenergize the marketing of its business strategy and Alpenglow®? brand in the coming weeks and months."

For more information on our facility and its technology, please visit: www.rmmi.ca

About RMMI Corp.

RMMI is an Alberta based company whose wholly owned subsidiary, Rocky Mountain Marijuana Inc., is licensed under the Cannabis Act (Canada) to cultivate, produce and sell marijuana in various forms. Rocky Mountain blends science with nature using aeroponic cultivation and CO2 extraction in the production of high-purity, organic-quality cannabis and cannabis oils. RMMI employs leading, commercially available science and technology to maximize production yields and product quality as a low-cost producer, while reducing risk to its crops and business.

Follow our Corporate Updates on Facebook at www.facebook.com/RMMICorp/ and on Twitter and Instagram at @RMMICorp.

Forward Looking Statements

Certain statements contained in this news release constitute "forward-looking statements" or "forward-looking information" within the meaning of the applicable securities legislation (collectively, "forward-looking statements"). These statements relate to management's expectations about future events, results of operations and RMMI's future performance (both operational and financial) and business prospects. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. Unless otherwise indicated, these statements speak only as of the date of this news release. In particular, this news release contains forward-looking statements pertaining RMMI's future business plans, Newell facility renovations and cultivation capacity.

Forward-looking statements are based on certain assumptions and analyses made by RMMI in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate and are subject to risks and uncertainties. In making the forward-looking statements, RMMI has made various material assumptions, including but not limited to, general business and economic conditions and RMMI's ability to successfully execute its business plans strategy. Although RMMI believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and RMMI cannot assure that actual results will be consistent with the forward-looking statements included in this news release. Given these risks, uncertainties and assumptions, readers should not place undue reliance on the forward-looking statements in this news release and should review the various risk factors set forth in RMMI's Annual Information Form dated February 28, 2019 found on SEDAR.

The forward-looking statements included in this news release are expressly qualified by this cautionary statement and, except as otherwise indicated, are made as of the date of this news release. RMMI does not undertake any obligation to publicly update or revise any forward-looking statements or departures from them except as required by applicable securities laws. All of the forward-looking statements contained in this news release are expressly qualified by the foregoing cautionary statements.

SOURCE RMMI


These press releases may also interest you

at 13:54
INOVAIT, the national network for commercializing breakthroughs in image-guided therapy (IGT) and artificial intelligence, presented the inaugural INOVAIT awards at its annual Discovery Forum last week (April 18, 2024). The awards were established to...

at 13:53
Medical device innovator and worldwide leader in minimally invasive neurosurgery NICO Corporation is launching its latest product innovation at next week's American Association of Neurosurgical Surgeons (AANS) Annual Scientific Meeting in Chicago,...

at 13:50
According to Arizton's latest focus research report, the US medical bathtubs market is growing at a CAGR of 2.27% during 2023-2029....

at 13:44
CellFE Inc., a life sciences tools company with a novel microfluidics-based cellular engineering platform, announced today an upcoming presentation by CSO Todd Sulchek, PhD, at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting,...

at 13:33
EHN Canada proudly announces a significant regional expansion of EHN Bellwood's legacy in pioneering addiction and mental health treatment centres....

at 13:30
CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners CARBIOS' first plant is also a world first using revolutionary enzymatic depolymerization technology, marking a major step forward in the...



News published on and distributed by: